Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
SFN 2022: Society for Neuroscience
The SFN: Society for Neuroscience 2022 will be held in-person in San Diego, CA from November 12-16.
Come and say hello to us as we showcase our range of preclinical systems! Meet us at booth 2603!
About the meeting:
Gather with the neuroscience community in San Diego for the return of SFN’s in-person annual meeting, featuring a robust, innovative program developed by neuroscientists from across the world. Share your research; find new collaborators; and attend an extraordinary array of lectures, exhibits, symposia, abstract presentations, professional development workshops, socials, and more.
When does the Meeting Take Place?
Sunday, November 13 – Wednesday, November 16, 2022
Where is this year’s SFN meeting?
San Diego Convention Center: 111 W Harbor Dr, San Diego, CA 92101, United States
Book a Meeting Here:
63
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders